Expression of Concern: Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.